The Impact of Functional Food on the Intestinal Microbiota in Relation to Chronic Noncommunicable Diseases

<p>The World Health Organization (WHO) states that obesity is characterized as a positive energy balance that favors the accumulation of fat, associated with metabolic complications related to health risks such as high cholesterol and triglyceride levels, high blood pressure, and resistance to...

Mô tả đầy đủ

Đã lưu trong:
Chi tiết về thư mục
Những tác giả chính: Rosângela dos Santos Ferreira (Tác giả), Rita de Cássia Avellaneda Guimarães (Tác giả), Ligia Aurélio Bezerra Maranhão Mendonça (Tác giả), Priscila Aiko Hiane (Tác giả)
Định dạng: Sách
Được phát hành: Annals of Pancreatic Disorders and Treatment - Peertechz Publications, 2017-02-27.
Những chủ đề:
Truy cập trực tuyến:Connect to this object online.
Các nhãn: Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_apdt_000002
042 |a dc 
100 1 0 |a Rosângela dos Santos Ferreira  |e author 
700 1 0 |a  Rita de Cássia Avellaneda Guimarães  |e author 
700 1 0 |a  Ligia Aurélio Bezerra Maranhão Mendonça  |e author 
700 1 0 |a Priscila Aiko Hiane  |e author 
245 0 0 |a The Impact of Functional Food on the Intestinal Microbiota in Relation to Chronic Noncommunicable Diseases 
260 |b Annals of Pancreatic Disorders and Treatment - Peertechz Publications,   |c 2017-02-27. 
520 |a <p>The World Health Organization (WHO) states that obesity is characterized as a positive energy balance that favors the accumulation of fat, associated with metabolic complications related to health risks such as high cholesterol and triglyceride levels, high blood pressure, and resistance to insulin [1].</p><p>These obesity-related alterations, such as high systemic blood pressure, dyslipidemia, high fasting glycemia, and central obesity, are the main characteristics of Metabolic Syndrome (MS), according to the International Diabetes Federation. MS is defined as the combination of physiological, biochemical, clinical, and metabolic factors associated with increased cardiovascular risk and the risk of type II diabetes mellitus [2].</p> 
540 |a Copyright © Rosângela dos Santos Ferreira et al. 
546 |a en 
655 7 |a Short Communication  |2 local 
856 4 1 |u https://doi.org/10.17352/apdt.000002  |z Connect to this object online.